Phoenix, AZ Clinical Trials Report — April 2026

For Phoenix residents considering participation in clinical research, April 2026 presents a critical window for those looking to join studies before enrollment concludes. Across Phoenix, 52 clinical trials are slated to close within the next 90 days, indicating an urgent need for participants. This includes opportunities for healthy volunteers, as 6 of these rapidly closing studies are still actively seeking individuals without specific health conditions. Anyone interested in contributing to medical advancements should explore these options promptly.

Impending Deadlines for Specific Conditions

Patients managing certain health conditions also face impending deadlines to join research. Trials focused on various conditions are among those with limited time remaining for enrollment. Conditions with trials closing soon include:

• Obesity (2 trials)
• Major depressive disorder (2 trials)
• Myasthenia gravis (2 trials)
• Atopic dermatitis (2 trials)
• Migraine (2 trials)
• Amyloid plaque (1 trial)
• Alzheimer disease (1 trial)
• Advanced NSCLC (1 trial)
• Asthma (1 trial)
• Alzheimer's disease (1 trial)

This month, Phoenix saw the opening of 4 new clinical trials, a decrease from the 10 trials that launched in March 2026. This trend reflects a broader pattern over the last six months, with new trial openings fluctuating from a high of 24 in December 2025 to 4 this April. Despite this dip in new openings, Phoenix remains a significant hub for medical research, with a total of 852 clinical trials currently recruiting across 414 research facilities.

Spotlight on New Research Opportunities

April brings several new trials to Phoenix, AZ, including significant Phase 2/3 studies from major sponsors. These trials offer participants the chance to engage with cutting-edge treatments and diagnostic approaches across a range of health challenges.

• Priovant Therapeutics, Inc. is sponsoring NCT07532603, "A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris." This study, aiming for 342 participants, will evaluate the clinical safety and efficacy of oral brepocitinib in individuals with lichen planopilaris.
• Eli Lilly and Company is launching NCT07533019, "A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo." This Phase 2 study seeks 60 participants to evaluate the tolerability and side effects of LY4005130 administered intravenously, compared with a placebo, in participants with non-segmental vitiligo (NSV).

New trials this month are exploring a range of conditions, including kidney stone, lichen planopilaris, non-segmental vitiligo (NSV), Parkinson disease, and vitiligo. Of the new studies, 3 are DRUG trials and 1 is a DEVICE trial. Notable sponsors for these new trials include Bial R&D Investments, S.A., Eli Lilly and Company, NYU Langone Health, and Priovant Therapeutics, Inc. The majority of these new trials, 3 out of 4, are sponsored by industry, with 1 sponsored by an academic or other institution.

For individuals without a specific medical condition, there are opportunities to contribute, although none of the 4 new trials launched this month are seeking healthy volunteers. However, across Phoenix, a total of 62 clinical trials are currently recruiting healthy participants, providing numerous avenues for those interested in supporting medical research.

Phoenix's Leading Research Facilities

Phoenix is home to several prominent research institutions that consistently run a high volume of clinical trials. These facilities are key destinations for individuals seeking to participate in medical research:

• Phoenix Children's Hospital (61 trials)
• Cancer Center at Saint Joseph's (50 trials)
• Mayo Clinic Hospital in Arizona (44 trials)
• Mayo Clinic Arizona (38 trials)
• Research Site (36 trials)
• Phoenix Childrens Hospital (36 trials)
• Mayo Clinic (32 trials)
• Barrow Neurological Institute (25 trials)
• Mayo Clinic Hospital (22 trials)
• St. Joseph's Hospital and Medical Center (16 trials)
• Arizona State University (13 trials)
• Mayo Clinic in Arizona (9 trials)

These institutions offer a broad spectrum of research, from pediatric care at Phoenix Children's Hospital to oncology at the Cancer Center at Saint Joseph's, and diverse medical fields across the various Mayo Clinic facilities and Barrow Neurological Institute.

Broadening Your Search: Nearby Options

While Phoenix offers a vast array of clinical trial opportunities, individuals may also find options in nearby communities within Arizona. Cities with active trials include Chandler (2 trials), Flagstaff (2 trials), Mesa (1 trial), Tempe (1 trial), and Tucson (1 trial).

Participation in clinical trials is open to a diverse range of individuals. Of the 4 new trials launched this month, 1 includes children and 4 include older adults, ensuring that both younger and senior populations have opportunities to contribute to medical science. As we move further into spring, the focus will remain on the ongoing enrollment in these significant studies and the continued exploration of new therapeutic strategies, with Phoenix's robust research community at the forefront of medical innovation.